Primary biliary cholangitis is a rare autoimmune disease that affects the liver and can progress to cirrhosis. It occurs when the immune system attacks the small bile ducts within the liver. As a ...

July 22 () - Pfizer said on Wednesday the U. Food ‌and Drug Administration has ‌granted priority review to its application ...

Patients with the most common molecular subtype of advanced breast cancer now have a targeted drug approved specifically for ...

On Wednesday, Defense Secretary Pete Hegseth made the startling announcement that the US military would begin requiring all ...

PDUFA target action date set to 18 December 2026LUND, Sweden, July 17, 2026 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that the US Food and Drug Administration (FDA) has accepted ...

WSW, NY, July 15th, 2026, FinanceWireOn July 6, 2026, Vertex Pharmaceuticals (NASDAQ: VRTX) agreed to acquire Crinetics ...

Crinetics adds potential best-in-class commercialized and Phase 3 endocrinology assets with ~$5 billion peak sales opportunity to Vertex's portfolio - PALSONIFY, Crinetics' recently launched, first ...

Prolactinomas are the most common functional pituitary neuroendocrine tumors, accounting for nearly half of all hormone-secreting pituitary adenomas. They can cause a wide range of symptoms, including ...

Prolactinomas are the most common functional pituitary neuroendocrine tumors, accounting for nearly half of all ...

Prolactinomas are the most common hormone-secreting pituitary tumors, but their diagnosis and management can be challenging ...

In a small cohort of patients with Cushing’s disease, most had their urinary free cortisol normalized after being ...

Vertex Pharma to buy Crinetics Pharmaceuticals for $10 billion: Boston Wednesday, July 8, 2026, 14:00 Hrs [IST] Vertex Pharmaceuticals Incorporated, a global biotechnology company ...